Mr John Richard

KANDO id: 1599

Bio

Has been an advisor to the Team for seven years and is Senior Business Advisor to GPC Biotech AG and a partner with Georgia Venture Partners, a seed stage venture company. Previously at Sequus where he was responsible for negotiating the acquisition of the company by Alza (a subsidiary of Johnson & Johnson) and he was the CEO and co-founder of Impath Inc, now part of Genzyme. Assists with strategic and commercial diligence activities and has represented Phase4 Ventures on the board of Altus, Targacept and Immgenics (acquired by Abgenix). Member of the Investment Committee. Currently represents Phase4 Ventures on the board of Zosano Pharma. MBA from Harvard. BS from Stanford.

Career


Nomura Phase4 Ventures Ltd

A global life sciences investor with a focus on development stage healthcare companies

Education